Publication | Closed Access

Use of Conventional or Replicating Nucleic Acid-Based Vaccines and Recombinant Semliki Forest Virus-Derived Particles for the Induction of Immune Responses Against Hepatitis C Virus Core and E2 Antigens

VaccinationVaccine DevelopmentVaccine TargetImmunologyNucleic Acid-based VaccinesHepatitisVirologyVaccine DesignPolyvalent VaccineMedicineVaccine ResearchE2 Antigens